Tonix Pharmaceuticals (NASDAQ:TNXP) Coverage Initiated by Analysts at StockNews.com
Stock analysts at StockNews.com assumed coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) in a research report issued to clients and investors on Sunday. The firm set a “sell” rating on the stock. Separately, Dawson James began coverage on Tonix Pharmaceuticals in a research note on Wednesday, February 28th. They issued a […]
More Stories
IAC (NASDAQ:IAC) & Eventbrite (NYSE:EB) Head to Head Analysis
Eventbrite (NYSE:EB – Get Free Report) and IAC (NASDAQ:IAC – Get Free Report) are both computer and technology companies, but...
Haiti: Child recruitment by armed groups surges 70 per cent
The number of children being recruited into armed groups across Haiti has increased by 70 per cent over the past...
Reviewing FFBW (NASDAQ:FFBW) & Carver Bancorp (NASDAQ:CARV)
Profitability This table compares FFBW and Carver Bancorp’s net margins, return on equity and return on assets. Net Margins Return...
Valuence Merger Corp. I (VMCA) & Its Rivals Financial Review
Volatility and Risk Valuence Merger Corp. I has a beta of 0.01, indicating that its stock price is 99% less...
Russia Will Help China Advance Submarine Technology, US Indo-Pacific Commander Says
By Frank Fang In return for China’s support during its war on Ukraine, Russia will likely assist Beijing to advance...
Financial Contrast: Carnival Co. & (NYSE:CUK) versus Viking (NYSE:VIK)
Viking (NYSE:VIK – Get Free Report) and Carnival Co. & (NYSE:CUK – Get Free Report) are both transportation companies, but...